A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation
Clinical trial NCT07668752 · RECRUITING
Trial details
- NCT number
- NCT07668752
- Sponsor
- Genfleet Therapeutics (Shanghai) Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-27
- Primary completion
- 2030-06-30
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.